Topics

Diffuse midline glioma | Treatment | Theranostics

Home > Publications > Topics > Diffuse midline glioma > Treatment > Theranostics

Pandit-Taskar N, Zanzonico PB, Grkovski M, Donzelli M, Vietri SM, Horan C, Serencsits B, Prasad K, Lyashchenko S, Kramer K, Dunkel IJ, Souweidane MM.
Theranostic Intratumoral Convection-Enhanced Delivery of ¹²⁴I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.
J Nucl Med. 2024 Aug 14:jnumed.123.266365. doi: 10.2967/jnumed.123.266365. PMID: 39142829. Observational study˰ ˍ

Souweidane MM, Bander ED, Zanzonico P, Reiner AS, Manino N, Haque S, Carrasquillo JA, Lyashchenko SK, Thakur SB, Lewis JS, Donzelli M, Cheung NV, Larson SM, Kramer K, Pandit-Taskar N, Dunkel IJ.
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG).
Neuro Oncol. 2025 Feb 19:noaf039. doi: 10.1093/neuonc/noaf039. PMID: 39969230. Interventional study˰ ˍ